CONMED (CNMD) Competitors $67.74 +0.89 (+1.32%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNMD vs. GKOS, STVN, BLCO, INSP, NARI, PRCT, NVST, IRTC, NVCR, and LIVNShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Envista (NVST), iRhythm Technologies (IRTC), NovoCure (NVCR), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. CONMED vs. Glaukos Stevanato Group Bausch + Lomb Inspire Medical Systems Inari Medical PROCEPT BioRobotics Envista iRhythm Technologies NovoCure LivaNova Glaukos (NYSE:GKOS) and CONMED (NYSE:CNMD) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking. Does the MarketBeat Community favor GKOS or CNMD? Glaukos received 412 more outperform votes than CONMED when rated by MarketBeat users. Likewise, 64.83% of users gave Glaukos an outperform vote while only 47.22% of users gave CONMED an outperform vote. CompanyUnderperformOutperformGlaukosOutperform Votes44664.83% Underperform Votes24235.17% CONMEDOutperform Votes3447.22% Underperform Votes3852.78% Do institutionals & insiders hold more shares of GKOS or CNMD? 99.0% of Glaukos shares are held by institutional investors. 6.4% of Glaukos shares are held by company insiders. Comparatively, 6.8% of CONMED shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is GKOS or CNMD more profitable? CONMED has a net margin of 10.23% compared to Glaukos' net margin of -42.43%. CONMED's return on equity of 13.84% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-42.43% -18.99% -11.47% CONMED 10.23%13.84%5.26% Which has better valuation and earnings, GKOS or CNMD? CONMED has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$314.71M27.44-$134.66M-$3.02-51.85CONMED$1.29B1.62$64.46M$4.2116.09 Does the media favor GKOS or CNMD? In the previous week, Glaukos had 1 more articles in the media than CONMED. MarketBeat recorded 6 mentions for Glaukos and 5 mentions for CONMED. CONMED's average media sentiment score of 1.33 beat Glaukos' score of 0.64 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, GKOS or CNMD? Glaukos has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, CONMED has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Do analysts rate GKOS or CNMD? Glaukos presently has a consensus price target of $147.75, indicating a potential downside of 5.65%. CONMED has a consensus price target of $79.80, indicating a potential upside of 17.79%. Given CONMED's higher possible upside, analysts plainly believe CONMED is more favorable than Glaukos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.85CONMED 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 SummaryCONMED beats Glaukos on 11 of the 19 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$2.09B$3.59B$5.36B$19.88BDividend Yield1.18%1.74%5.13%3.70%P/E Ratio16.0918.6889.4741.44Price / Sales1.6273.621,262.7017.21Price / Cash11.3641.1043.7519.84Price / Book2.503.915.325.73Net Income$64.46M$96.59M$122.60M$993.95M7 Day Performance-1.52%3.48%0.69%3.14%1 Month Performance-4.89%3.30%1.55%1.89%1 Year Performance-38.13%6.16%27.25%19.67% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.7698 of 5 stars$67.75+1.3%$79.80+17.8%-38.1%$2.09B$1.29B16.094,000GKOSGlaukos3.5842 of 5 stars$152.27-2.7%$147.75-3.0%+75.2%$8.40B$360.35M-50.42780Short Interest ↑STVNStevanato GroupN/A€22.11-3.6%N/A-16.2%$6.53B$1.09B47.045,635Gap DownBLCOBausch + Lomb2.9287 of 5 stars$17.28-2.7%$20.58+19.1%+18.0%$6.09B$4.68B-16.4613,300Analyst ForecastINSPInspire Medical Systems4.8442 of 5 stars$175.94-13.1%$233.58+32.8%-5.2%$5.27B$755.59M164.431,011Gap DownHigh Trading VolumeNARIInari Medical1.5468 of 5 stars$79.36+0.1%$68.00-14.3%+36.7%$4.65B$574.50M-58.78800PRCTPROCEPT BioRobotics2.5134 of 5 stars$82.72-4.8%$97.86+18.3%+64.0%$4.32B$199.84M-42.42430News CoverageNVSTEnvista3.4974 of 5 stars$19.08+2.7%$20.21+5.9%-14.0%$3.28B$2.50B-2.4612,700News CoverageIRTCiRhythm Technologies1.4425 of 5 stars$94.81-3.0%$108.45+14.4%-2.0%$2.97B$560.03M-19.511,790NVCRNovoCure3.1156 of 5 stars$26.70-2.7%$32.67+22.3%+110.7%$2.89B$577.74M-19.071,320Analyst ForecastAnalyst RevisionNews CoverageLIVNLivaNova3.5627 of 5 stars$47.51+1.8%$69.17+45.6%-4.2%$2.58B$1.15B113.122,900Analyst Upgrade Related Companies and Tools Related Companies GKOS Competitors STVN Competitors BLCO Competitors INSP Competitors NARI Competitors PRCT Competitors NVST Competitors IRTC Competitors NVCR Competitors LIVN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNMD) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNMD Stock Alerts